Mark Wallace - Escalon Medical COO Officer
| ESMCDelisted Stock | USD 0.06 0.00 0.00% |
COO
Mr. Mark G. Wallace serves as Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer of Escalon Medical Corporationration since January 1, 2008 since 2017.
| Age | 53 |
| Tenure | 7 years |
| Phone | 610 688 6830 |
| Web | https://www.escalonmedical.com |
Mark Wallace Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Wallace against Escalon Medical otc stock is an integral part of due diligence when investing in Escalon Medical. Mark Wallace insider activity provides valuable insight into whether Escalon Medical is net buyers or sellers over its current business cycle. Note, Escalon Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Escalon Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Wallace over three months ago Payment of 447 shares by Mark Wallace of Keysight Technologies subject to Rule 16b-3 | ||
Mark Wallace over three months ago Acquisition by Mark Wallace of 11499 shares of Keysight Technologies subject to Rule 16b-3 | ||
Mark Wallace over three months ago Acquisition by Mark Wallace of 11499 shares of Keysight Technologies subject to Rule 16b-3 | ||
Mark Wallace over six months ago Acquisition by Mark Wallace of 24281 shares of Uniti subject to Rule 16b-3 |
Escalon Medical Management Efficiency
The company has return on total asset (ROA) of (0.0724) % which means that it has lost $0.0724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4225) %, meaning that it created substantial loss on money invested by shareholders. Escalon Medical's management efficiency ratios could be used to measure how well Escalon Medical manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 153.43 K in liabilities with Debt to Equity (D/E) ratio of 0.82, which is about average as compared to similar companies. Escalon Medical Corp has a current ratio of 1.36, which is within standard range for the sector. Debt can assist Escalon Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Escalon Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Escalon Medical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Escalon to invest in growth at high rates of return. When we think about Escalon Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 1 records | COO Age | ||
| Edward Smolyansky | Lifeway Foods | 37 | |
Management Performance
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0724 |
Escalon Medical Corp Leadership Team
Elected by the shareholders, the Escalon Medical's board of directors comprises two types of representatives: Escalon Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Escalon. The board's role is to monitor Escalon Medical's management team and ensure that shareholders' interests are well served. Escalon Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Escalon Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Todd Trusk, Director | ||
| Fred Choate, Independent Director | ||
| Richard DePiano, CEO and President General Counsel and Director | ||
| Sean Closkey, Independent Director | ||
| John Dogum, Director | ||
| Mark Wallace, COO Officer | ||
| Lisa Napolitano, Independent Director | ||
| Robert Oconnor, CFO | ||
| David Jacovini, Director |
Escalon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Escalon Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0724 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 2.07 M | ||||
| Shares Outstanding | 7.42 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Number Of Shares Shorted | 2.01 K | ||||
| Price To Earning | 4.50 X | ||||
| Price To Book | 1.12 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Escalon Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Escalon Medical's short interest history, or implied volatility extrapolated from Escalon Medical options trading.
Pair Trading with Escalon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Escalon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Escalon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Escalon OTC Stock
| 0.72 | OM | Outset MedicalInc Financial Report 1st of May 2024 | PairCorr |
| 0.75 | VERO | Venus Concept Financial Report 20th of May 2024 | PairCorr |
Moving against Escalon OTC Stock
| 0.8 | ESTA | Establishment Labs Financial Report 13th of May 2024 | PairCorr |
| 0.79 | BSX | Boston Scientific Corp Earnings Call This Week | PairCorr |
| 0.77 | ELMD | Electromed | PairCorr |
| 0.75 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
| 0.58 | DXCM | DexCom Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Escalon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Escalon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Escalon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Escalon Medical Corp to buy it.
The correlation of Escalon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Escalon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Escalon Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Escalon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Escalon OTC Stock
If you are still planning to invest in Escalon Medical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Escalon Medical's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |